Janssen Research & Development, L.L.C., a division of Johnson & Johnson's Family of Companies is recruiting for a Sr. Director, Compound Development Team Leader in the Prostate Cancer Disease area, located either in Spring House, PA, Raritan NJ, Los Angeles CA, or La Jolla CA.
The CDTL provides leadership to a cross-functional strategic compound development team and leads the development and execution of the compound strategy. Further, the CDTL champions the product/brand at all levels of J&J and is responsible for managing the alignment on communication on all CDT matters, as appropriate.
Actively contributes to Compound Strategy decision-making by ensuring relevant research, analysis, and expertise are available. Rapidly integrates data across functions to drive efficient decision making. Leads CDT in partnership with line functions and Prostate Disease Area Stronghold (DAS) to successfully develop the compound such that its value is maximized over its lifecycle while costs and time
are minimized without sacrificing quality. Builds team effectiveness, and leads the Compound Development Team (CDT) to achieve its goals through the networks of people/functions represented on the team. When necessary, negotiates with function heads on functional deliverables. In partnership with the Prostate DAS, actively builds and fosters external investigator relationships to facilitate clinical
development including pre-clinical and correlative clinical collaborative studies. Challenges all functions on CDT to ensure that all issues and questions are being addressed, and that line function input into strategy and plans is adequate to meet the needs of the compound. Partners with internal clinical leads to actively monitor emerging clinical developments from internal and external trials
and rapidly adapts into clinical development strategy. Leads the development and maintenance of the compound development strategy in collaboration with the Project Manager (PM). Identifies potential issues and leads contingency planning; leads CDT problem solving and applies decision-making tools and techniques. Drives CDT to make effective and efficient decisions. Leads resolution of conflict within the CDT, Oncology Senior Leadership Team (ONC SLT), Development Committee (DC), Group Operating Committee (GOC) and joint steering committees for partnered compounds and senior management levels. Ensures successful implementation of clinical supplies strategy. Accountable for overall budget and project plan deliverables. Acts as co-chair of global project teams with Alliance partners and aligns global strategy within a partnership, as applicable.
Accountable for driving compound publication strategy and advisory boards. Ensures lessons learned at critical nodes in the development path. Leads the communication of strategy, issues, and plans to the DAS, PMC, ONC SLT, DC, IC, GOC, alliance partners, JPKK, regional management boards, and other key stakeholders. Builds and maintains team effectiveness and satisfaction.
Drives innovation by benchmarking. Works with functional management to secure the required resources for project success, influence optimal team composition, align goals and objectives with CDT members, coach and guide CDT members and to provide input for performance evaluation of CDT members.
- Candidate must hold a PhD, MD or M.D./Ph.D with minimum of 8-10 years, or Masters with 10-12 years’ experience in a leadership role as a part of a research-driven pharmaceutical company.
- Qualified candidates will have demonstrated a solid understanding of and involvement in the entire drug development process but experience in leading oncology clinical development programs with an emphasis on phase I/II development is preferred.
- He or she should have proven ability to work cross-functionally with interdisciplinary teams to access and optimize resources for development programs and experience working in a matrix organization.
- Additionally, qualified candidates will have a proven track-record building and maintaining productive translational research collaborations to support a clinical development strategy.
- Candidate should be business orientated, having managed resources and budgets with proven record of leading projects through successful transition from Discovery to Early Development and advancement of projects through preclinical and clinical development to Phase 2b within the oncology therapeutic area.
- Excellent communication and leadership skills are a must, and a strong track record of producing results in a matrix-based environment is essential.
- Candidates should have a strong scientific foundation in oncology drug discovery and have demonstrated to effectively partner with expert investigators to drive clinical development.
- Domestic and international travel may be required of approximately 10 - 25% (depending on the compound type and stage of development).
- This is a role that should be filled by a high performing individual who demonstrates outstanding leadership, influence, and communication skills.
- Strong problem-solving skills for developing creative solutions and meeting project objectives is required.
- Strong project planning and tracking skills. Demonstrated ability for strategic thinking and contingency planning.
- Expert knowledge of the drug development process and familiarity with pharmaceutical portfolio risk management is required.
United States-Pennsylvania-Spring House-
North America-United States, North America-United States-California-La Jolla, United States-New Jersey-Raritan, United States-California-Los Angeles
Janssen Research & Development, LLC (6084)